Eli Lilly 2011 Annual Report Download - page 99

PROXY STATEMENT
Franklyn G. Prendergast, M.D., Ph.D. Age 66 Director since 1995
Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular
Pharmacology and Experimental Therapeutics, Mayo Medical School; and Director, Mayo Clinic Center for
Individualized Medicine
Dr. Prendergast is the Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and
Professor of Molecular Pharmacology and Experimental Therapeutics at Mayo Medical School and the director of the
Mayo Clinic Center for Individualized Medicine. He has held several other teaching positions at the Mayo Medical
School since 1975.
Qualifications: Dr. Prendergast is a prominent medical clinician, researcher, and academician. He has extensive
experience in senior-most administration at Mayo Clinic, a major medical institution, and as director of its renowned
cancer center. He has special expertise in two critical areas for Lilly—oncology and personalized medicine. As a
medical doctor, he brings an important practicing-physician perspective to the board’s deliberations.
Board committees: public policy and compliance; science and technology
Kathi P. Seifert Age 62 Director since 1995
Retired Executive Vice President, Kimberly-Clark Corporation
Ms. Seifert served as executive vice president for Kimberly-Clark Corporation until June 2004. She joined Kimberly-
Clark in 1978 and served in several capacities in connection with both the domestic and international consumer-
products businesses. Prior to joining Kimberly-Clark, Ms. Seifert held management positions at Procter & Gamble,
Beatrice Foods, and Fort Howard Paper Company. She is chairman of Katapult, LLC. Ms. Seifert serves on the
boards of Supervalu Inc.; Revlon Consumer Products Corporation; Lexmark International, Inc.; Appleton Papers Inc.;
the U.S. Fund for UNICEF; and the Fox Cities Performing Arts Center.
Qualifications: Ms. Seifert is a retired senior executive of Kimberly-Clark, a global consumer products company. She
has strong expertise in consumer marketing and brand management, having led sales and marketing for several
worldwide brands, with a special focus on consumer health. She has extensive corporate governance experience
through her other board positions.
Board committees: audit; compensation
Class of 2014
The following four directors will continue in office until 2014.
Michael L. Eskew Age 62 Director since 2008
Former Chairman and Chief Executive Officer, United Parcel Service, Inc.
Mr. Eskew served as chairman and chief executive officer of United Parcel Service, Inc., from January 2002 until
December 2007. He continues to serve on the UPS board of directors. Mr. Eskew began his UPS career in 1972 as an
industrial engineering manager and held various positions of increasing responsibility, including time with UPS’s
operations in Germany and with UPS Airlines. In 1993, Mr. Eskew was named corporate vice president for industrial
engineering. Two years later he became group vice president for engineering. In 1998, he was elected to the UPS
board of directors. In 1999, Mr. Eskew was named executive vice president and a year later was given the additional
title of vice chairman. He serves as chairman of the board of trustees of The Annie E. Casey Foundation. Mr. Eskew
also serves on the boards of 3M Corporation and IBM Corporation.
Qualifications: Mr. Eskew has CEO experience with UPS, where he established a record of success in managing
complex worldwide operations, strategic planning, and building a strong consumer-brand focus. He is an audit
committee financial expert, based on his CEO experience and his service on other U.S. company audit committees.
He has extensive corporate governance experience through his service on the boards of other companies.
Board committees: audit (chair); compensation
9